Valuation: TAKE LIMITED

Market Cap 1.77B 18.77M 16.73M 15.3M 13.93M 26.26M 26.97M 184M 73.49M 939M 70.45M 68.94M 2.96B P/E 2025
2.61x
P/E 2026 53.5x
Enterprise Value 1.59B 16.82M 14.99M 13.71M 12.48M 23.53M 24.17M 165M 65.85M 842M 63.13M 61.77M 2.66B EV / Sales 2025
-
EV / Sales 2026 10.5x
Free-Float
37.81%
Yield 2025 *
-
Yield 2026 -
1 day+4.99%
1 week+13.76%
Current month+12.48%
1 month-5.22%
3 months-46.45%
6 months-70.44%
Current year-69.98%
1 week 10.22
Extreme 10.22
11.99
1 month 9.88
Extreme 9.88
13.35
Current year 9.88
Extreme 9.88
50.14
1 year 9.88
Extreme 9.88
50.14
3 years 6.51
Extreme 6.51
50.14
5 years 6.51
Extreme 6.51
51.75
10 years 6.51
Extreme 6.51
308.25
Manager TitleAgeSince
Compliance Officer - 2026-01-27
Chief Tech/Sci/R&D Officer 56 -
Director TitleAgeSince
Director/Board Member - 2025-05-23
Director/Board Member 44 2025-05-23
Director/Board Member 47 2025-05-23
Change 5-day change 1-year change 3-year change Capi.($)
+4.99%+13.76%-49.77%-39.75% 17.88M
+3.80%+8.47%+64.65%+77.70% 66.87B
+1.63%+6.76%+24.52%+104.31% 56.55B
+0.07%+2.39%+11.12%+75.17% 57.2B
+0.41%-3.70%+26.06%+33.51% 43.47B
-11.04%-6.63%+199.38%+724.74% 42.8B
+2.51%+4.22%+20.49%+97.44% 42.95B
+1.59%-6.02%+92.48%+79.95% 32.11B
+7.50%+13.28%+28.05%+64.46% 34.01B
-1.13%-2.54%-41.80%+356.21% 24.13B
Average +1.28%+4.42%+37.52%+157.37% 40.01B
Weighted average by Cap. +0.97%+3.91%+49.50%+163.48%

Financials

2025 2026
Net sales - 542M 5.73M 5.11M 4.67M 4.26M 8.02M 8.24M 56.14M 22.45M 287M 21.52M 21.06M 906M
Net income 375M 3.96M 3.53M 3.23M 2.94M 5.55M 5.7M 38.82M 15.52M 198M 14.88M 14.56M 626M 108M 1.15M 1.02M 936K 852K 1.61M 1.65M 11.24M 4.5M 57.46M 4.31M 4.22M 181M
Net Debt -33.71M -357K -318K -291K -265K -499K -513K -3.49M -1.4M -17.85M -1.34M -1.31M -56.33M -184M -1.95M -1.74M -1.59M -1.45M -2.73M -2.8M -19.11M -7.64M -97.66M -7.32M -7.17M -308M
Projected Income Statement - Annual - TAKE LIMITED
Logo TAKE LIMITED
Take Limited, formerly Take Solutions Limited, is an India-based contract research organization (CRO), which is engaged in supporting pharma, biotech and devices companies. The Company offers clients a combination of full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry network forums. Its digital healthcare services include medical decision-making (artificial intelligence and machine learning), and cloud adoption & mobility. Its global roster of clients includes large and small biopharmaceutical and device companies, United States federal agencies like the Centers for Disease Control and Prevention (CDC) and the United States Department of Defense (DoD), as well as generics manufacturers. The Company's subsidiary is Ecron Acunova Limited.
Employees
5
Date Price Change Volume
26-11-05 ₹11.99 +4.99% 128,283
26-11-04 ₹11.42 +4.96% 147,031
26-11-03 ₹10.88 -1.89% 135,993
26-11-02 ₹11.09 +4.03% 497,432
26-10-30 ₹10.66 -3.62% 799,840
  1. Stock Market
  2. Stocks
  3. TAKE Stock